Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (51-60 of 6,821) with videos related to

Pageof 683
Sort By:
Nature Reviews. Drug Discovery|April 10, 2020
Coordinating the COVID-19 pipelineAsher Mullard
Nature Reviews. Drug Discovery|September 5, 2025
First protease activator secures FDA approval for rare brain cancerAsher Mullard
Nature Reviews. Drug Discovery|September 8, 2025
FDA approves anti-prekallikrein drug for hereditary angioedemaAsher Mullard
Nature Reviews. Drug Discovery|June 2, 2015
Regulators and industry tackle dose-finding issuesAsher Mullard
Nature Reviews. Drug Discovery|May 20, 2021
Will psychedelics be 'a revolution in psychiatry'?Asher Mullard
Nature Reviews. Drug Discovery|May 13, 2021
FDA approves ADC Therapeutics' loncastuximab tesirine, ushering in a new cytotoxic payloadAsher Mullard
Nature Reviews. Drug Discovery|August 7, 2021
FDA approves first all-oral sleeping sickness drugAsher Mullard
Nature Reviews. Drug Discovery|August 7, 2021
FDA approves AstraZeneca's anifrolumab for lupusAsher Mullard
Nature Reviews. Drug Discovery|February 9, 2023
New dose optimization guidance released for cancer drugsAsher Mullard
Journal of Molecular Graphics & Modelling|August 10, 2000
Decision analytics software solutions for proteomics analysisB Asher
Pageof 683

Showing results (51-60 of 6,821) with videos related to

Sort By:
Pageof 683
Nature Reviews. Drug Discovery|April 10, 2020
Coordinating the COVID-19 pipelineAsher Mullard
Nature Reviews. Drug Discovery|September 5, 2025
First protease activator secures FDA approval for rare brain cancerAsher Mullard
Nature Reviews. Drug Discovery|September 8, 2025
FDA approves anti-prekallikrein drug for hereditary angioedemaAsher Mullard
Nature Reviews. Drug Discovery|June 2, 2015
Regulators and industry tackle dose-finding issuesAsher Mullard
Nature Reviews. Drug Discovery|May 20, 2021
Will psychedelics be 'a revolution in psychiatry'?Asher Mullard
Nature Reviews. Drug Discovery|May 13, 2021
FDA approves ADC Therapeutics' loncastuximab tesirine, ushering in a new cytotoxic payloadAsher Mullard
Nature Reviews. Drug Discovery|August 7, 2021
FDA approves first all-oral sleeping sickness drugAsher Mullard
Nature Reviews. Drug Discovery|August 7, 2021
FDA approves AstraZeneca's anifrolumab for lupusAsher Mullard
Nature Reviews. Drug Discovery|February 9, 2023
New dose optimization guidance released for cancer drugsAsher Mullard
Journal of Molecular Graphics & Modelling|August 10, 2000
Decision analytics software solutions for proteomics analysisB Asher
Pageof 683